Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 82 total PSOs listed by AHRQ.

Alliance for Patient Medication Safety
PSO Number: P0020
Component of Parent Org(s):
  • NASPA
Effective Date and Time of Initial Listing: December 10, 2008 12:01 AM ET
Street Address: 2530 Professional Road, Suite 202, Richmond, Virginia 23235
PSO Phone Number: (804) 422-6311
Fax: (804) 612-6555
Point of Contact: Taramarie (Tara) Modisett
Point of Contact Phone: (804) 422-6311
Point of Contact Email: tara@naspa.us (link is external)
Next biennial attestation for Two Contracts due between 12/10/2018 and 12/09/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Center for the Assessment of Radiological Sciences PSO
PSO Number: P0149
Component of Parent Org(s):
  • Center for the Assessment of Radiological Sciences
Effective Date and Time of Initial Listing: August 28, 2013 12:01 AM ET
Street Address: 4913 Waukesha Street, Madison, Wisconsin 53705
PSO Phone Number: (608) 345-5795
Fax: (608) 262-2413
Point of Contact: Bruce Thomadsen
Point of Contact Phone: (608) 345-5795
Point of Contact Email: brthomad@cars-pso.org (link is external)
Next biennial attestation for Two Contracts due between 08/28/2019 and 08/27/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
DARTNet Institute Patient Safety Organization
PSO Number: P0176
Component of Parent Org(s):
  • DARTNet Institute
Effective Date and Time of Initial Listing: December 22, 2015 12:01 AM ET
Street Address: 12635 East Montview Blvd, Aurora, Colorado 80045
PSO Phone Number: (800) 434-0278
Fax: (214) 594-9583
Point of Contact: Deborah Graham
Point of Contact Phone: (800) 434-0278, ext. 2
Point of Contact Email: deborah.graham@dartnet.info (link is external)
Next biennial attestation for Two Contracts due between 12/22/2017 and 12/21/2019
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Enterprise Patient Safety Organization, L.L.C
PSO Number: P0155
Component of Parent Org(s):
  • CVS Pharmacy, Inc.
Effective Date and Time of Initial Listing: April 22, 2014 12:01 AM ET
Street Address: 200 Highland Corporate Drive, MD 2345, Cumberland, Rhode Island 02864
PSO Phone Number: (401) 770-5215
Fax: (401) 652-9252
Point of Contact: Susan Cornacchio
Point of Contact Phone: (401) 770-2182
Point of Contact Email: Susan.Cornacchio@CVSHealth.com (link is external)
Next biennial attestation for Two Contracts due between 04/22/2018 and 04/21/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
HCA Patient Safety Organization, LLC
PSO Number: P0157
Component of Parent Org(s):
  • HCA Holdings, Inc. (direct parent: EP Holdco, LLC)
Effective Date and Time of Initial Listing: April 9, 2014 12:01 AM ET
Street Address: One Park Plaza, Nashville, Tennessee 37203
PSO Phone Number: (615) 344-2293
Fax: (877) 907-6903
Point of Contact: Ruth O. Westcott RN, BSN
Point of Contact Phone: (615) 344-2322
Point of Contact Email: ruth.westcott@hcahealthcare.com (link is external)
Next biennial attestation for Two Contracts due between 04/09/2018 and 04/08/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Institute for Safe Medication Practices (ISMP)
PSO Number: P0009
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 200 Lakeside Drive, Suite 200, Horsham, Pennsylvania 19044
PSO Phone Number: (215) 947-7797
Fax: (215) 914-1492
Point of Contact: Ann D. Shastay RN, MSN, AOCN
Point of Contact Phone: (215) 947-7797
Point of Contact Email: ashastay@ismp.org (link is external)
Next biennial attestation for Two Contracts due between 11/05/2018 and 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
QA to QI LLC
PSO Number: P0091
Effective Date and Time of Initial Listing: June 30, 2010 12:01 AM ET
Street Address: 111 Hunter Drive, West Hartford , Connecticut 06107-1018
PSO Phone Number: (860) 521-8484
Point of Contact: Marc T Edwards MD, MBA
Point of Contact Phone: (860) 521-8484
Point of Contact Email: Marc@QAtoQI.com (link is external)
Next biennial attestation for Two Contracts due between 06/30/2018 and 06/29/2020
Disclosures & Finding: The Department of Health and Human Services determined no action was required regarding the PSO's relationships with the following contracting provider(s):
  • St. Joseph's Hospital, Syracuse, NY
Subject to FDA-Regulated Reporting Entity Guidance: No
QCMetrix PSO
PSO Number: P0166
Component of Parent Org(s):
  • QCMetrix
Effective Date and Time of Initial Listing: April 16, 2015 12:01 AM ET
Street Address: 1101 Worcester Road, Framingham, Massachusetts 01701
PSO Phone Number: (781) 290-5900
Fax: (781) 290-0619
Point of Contact: Peter Shurtleff
Point of Contact Phone: (774) 644-2915
Point of Contact Email: pshurtleff@qcmetrix.com (link is external)
Next biennial attestation for Two Contracts due between 04/16/2017 and 04/15/2019
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
The Envision Healthcare Center for Quality and Patient Safety, LLC
PSO Number: P0197
Component of Parent Org(s):
  • Envision Healthcare
Effective Date and Time of Initial Listing: October 19, 2017 12:01 AM ET
Street Address: 1A Burton Hills Boulevard, Nashville, Tennessee 37215
PSO Phone Number: (615) 665-3558
Fax: (615) 234-1458
Point of Contact: Debbie Cibulka
Point of Contact Phone: (615) 665-3558
Point of Contact Email: dcibulka@amsurg.com (link is external)
Next biennial attestation for Two Contracts due between 10/19/2017 and 10/18/2019
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
The PSO Advisory, LLC
PSO Number: P0089
Effective Date and Time of Initial Listing: May 5, 2010 12:01 AM ET
Street Address: 30 Cargill Rd, Cumberland, Rhode Island 02864
PSO Phone Number: (401) 228-7590
Fax: (401) 465-6979
Point of Contact: William P Smith RPH, MS
Point of Contact Phone: 401-228-7590
Point of Contact Email: wpsmith@thepsoadvisory.com (link is external)
Next biennial attestation for Two Contracts due between 05/05/2018 and 05/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
The Patient Safety Research Foundation, Inc.
PSO Number: P0043
Component of Parent Org(s):
  • Walgreen Co.
Effective Date and Time of Initial Listing: January 14, 2009 12:01 AM ET
Street Address: 200 Wilmot Road MS-2194, Deerfield, Illinois 60015-4681
PSO Phone Number: (847) 315-3379
Fax: (847) 315-3109
Point of Contact: Natasha Farah Polster RPh
Point of Contact Phone: (847) 315-3379
Point of Contact Email: tasha.polster@walgreens.com (link is external)
Next biennial attestation for Two Contracts due between 01/14/2017 and 01/13/2019
Disclosures & Finding:
Subject to FDA-Regulated Reporting Entity Guidance: Yes
USAP PSO
PSO Number: P0178
Component of Parent Org(s):
  • United States Anesthesia Partners
Effective Date and Time of Initial Listing: June 15, 2016 12:01 AM ET
Street Address: 6606 LBJ Freeway, Suite 200, Dallas, Texas 75240
PSO Phone Number: 972-663-8522
Fax: 972-715-9992
Point of Contact: Richard P. Dutton MD, MBA
Point of Contact Phone: 972-663-8522
Point of Contact Email: richard.dutton@usap.com (link is external)
Next biennial attestation for Two Contracts due between 06/15/2018 and 06/14/2020
Disclosures & Finding:
Subject to FDA-Regulated Reporting Entity Guidance: No